Evidence map›Paper›PMID 38565543›Full record

ArticleNature communications2024

Early detection of emerging viral variants through analysis of community structure of coordinated substitution networks.

Fatemeh Mohebbi, Alex Zelikovsky, Serghei Mangul, Gerardo Chowell, Pavel Skums

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fatemeh MohebbiDepartment of Computer Science, Georgia State University, Atlanta, GA, USA.ORCID http://orcid.org/0000-0003-1395-1051
Alex ZelikovskyDepartment of Computer Science, Georgia State University, Atlanta, GA, USA.
Serghei MangulTitus Family Department of Clinical Pharmacy, USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0003-4770-3443
Gerardo ChowellSchool of Public Health, Georgia State University, Atlanta, GA, USA.
Pavel SkumsDepartment of Computer Science, Georgia State University, Atlanta, GA, USA. pavel.skums@uconn.edu.ORCID http://orcid.org/0000-0003-4007-5624

Funding

Developing robust and scalable genomics tools and databases to analyze immune receptor repertoires across diverse populationsR01AI173172 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ALACHKAR, HOUDA · 2023 to 2025
$2.5M
Chemo-neoepitopes as novel immunotherapy for triple negative breast cancerR21CA241044 · NCI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI IONOV, YURIJ, MANDOIU, ION · 2021 to 2021
$467k
NCI NIH HHS R21 CA241044NIAID NIH HHS R01 AI173172
6 · The paper itself

Abstract

The emergence of viral variants with altered phenotypes is a public health challenge underscoring the need for advanced evolutionary forecasting methods. Given extensive epistatic interactions within viral genomes and known viral evolutionary history, efficient genomic surveillance necessitates early detection of emerging viral haplotypes rather than commonly targeted single mutations. Haplotype inference, however, is a significantly more challenging problem precluding the use of traditional approaches. Here, using SARS-CoV-2 evolutionary dynamics as a case study, we show that emerging haplotypes with altered transmissibility can be linked to dense communities in coordinated substitution networks, which become discernible significantly earlier than the haplotypes become prevalent. From these insights, we develop a computational framework for inference of viral variants and validate it by successful early detection of known SARS-CoV-2 strains. Our methodology offers greater scalability than phylogenetic lineage tracing and can be applied to any rapidly evolving pathogen with adequate genomic surveillance data.

Indexed as

Biological EvolutionGenome, ViralEarly DiagnosisGenomicsPhylogenySARS-CoV-2

Identifiers

PMID38565543
PMCPMC10987511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.